**
Overview
Mitochondrial Myopathies (MMs) are a group of rare, inherited disorders that affect the mitochondria, the energy-producing structures within cells. These conditions are caused by mutations in the mitochondrial DNA, which is separate from the DNA found in the cell's nucleus. MMs primarily affect the muscles, leading to a range of symptoms, including muscle weakness, fatigue, and pain. The disorders are often characterized by a combination of muscle and neurological symptoms, and can affect individuals of all ages.
Mitochondrial Myopathies are a complex and heterogeneous group of conditions, with over 150 different mutations identified. The disorders are often inherited in an autosomal dominant or maternal pattern, meaning that a single copy of the mutated gene is enough to cause the condition. The severity and progression of MMs can vary widely, with some individuals experiencing mild symptoms that remain stable over time, while others may experience rapid progression and significant disability.
History/Background
The first descriptions of Mitochondrial Myopathies date back to the 1960s, when researchers began to identify cases of progressive external ophthalmoplegia (PEO), a condition characterized by weakness and paralysis of the eye muscles. In the 1980s, researchers discovered that PEO was caused by mutations in the mitochondrial DNA, leading to the identification of the first mitochondrial myopathy. Since then, numerous other mitochondrial myopathies have been identified, including Kearns-Sayre syndrome, MELAS syndrome, and myoclonic epilepsy with ragged-red fibers (MERRF).
Key Information
Mitochondrial Myopathies are characterized by a range of symptoms, including:
* Muscle weakness and fatigue
* Pain and stiffness in the muscles
* Weakness and paralysis of the eye muscles (PEO)
* Seizures and epilepsy
* Hearing loss and vision loss
* Cognitive impairment and dementia
The disorders are often diagnosed through a combination of clinical evaluation, genetic testing, and muscle biopsy. Treatment options are limited, and typically focus on managing symptoms and slowing disease progression. In some cases, individuals with MMs may require assistive devices, such as wheelchairs or communication aids.
Significance
Mitochondrial Myopathies are a significant public health concern, affecting an estimated 1 in 5,000 individuals worldwide. The disorders are often diagnosed in childhood or adolescence, and can have a profound impact on an individual's quality of life. While there is currently no cure for MMs, research is ongoing to identify new treatments and improve our understanding of these complex disorders.
INFOBOX:
- Name: Mitochondrial Myopathies
- Type: Rare genetic disorders
- Date: 1960s (first descriptions)
- Location: Global
- Known For: Complex and heterogeneous group of conditions affecting the mitochondria
TAGS: Mitochondrial Myopathies, Rare Genetic Disorders, Muscle Weakness, Fatigue, Pain, Progressive External Ophthalmoplegia, Kearns-Sayre Syndrome, MELAS Syndrome, MERRF, Genetic Testing, Muscle Biopsy.
